Treatment choice in single-sided deafness ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
Treatment choice in single-sided deafness and asymmetric hearing loss. A prospective, multi-center cohort study on 155 patients.
Author(s) :
Marx, Mathieu [Auteur]
Centre de recherche cerveau et cognition [CERCO UMR5549]
Mosnier, Isabelle [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Vincent, Christophe [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Bonne, Nicolas - Xavier [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 [PRISM]
Bakhos, David [Auteur]
Hôpital Bretonneau
Lescanne, Emmanuel [Auteur]
Hôpital Bretonneau
Flament, Jonathan [Auteur]
CIC AP-HP [CHU Pitié-Salpêtrière]
Bernardeschi, Danièle [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Sterkers, Olivier [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Fraysse, Bernard [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Lepage, Benoît [Auteur]
Université Toulouse III - Paul Sabatier [UT3]
Godey, Benoît [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Schmerber, Sébastien [Auteur]
Uziel, Alain [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Mondain, Michel [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Deguine, Olivier [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Centre de recherche cerveau et cognition [CERCO UMR5549]
Mosnier, Isabelle [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Vincent, Christophe [Auteur]

Advanced Drug Delivery Systems (ADDS) - U1008
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Bonne, Nicolas - Xavier [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 [PRISM]
Bakhos, David [Auteur]
Hôpital Bretonneau
Lescanne, Emmanuel [Auteur]
Hôpital Bretonneau
Flament, Jonathan [Auteur]
CIC AP-HP [CHU Pitié-Salpêtrière]
Bernardeschi, Danièle [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Sterkers, Olivier [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Fraysse, Bernard [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Lepage, Benoît [Auteur]
Université Toulouse III - Paul Sabatier [UT3]
Godey, Benoît [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Schmerber, Sébastien [Auteur]
Uziel, Alain [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Mondain, Michel [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Deguine, Olivier [Auteur]
Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier]
Journal title :
Clinical Otolaryngology
Abbreviated title :
Clin Otolaryngol
Volume number :
46
Pages :
736-743
Publisher :
Wiley Online Library
Publication date :
2020-11-29
ISSN :
1749-4486
Keyword(s) :
asymmetric hearing loss
BAHA
binaural hearing
cochlear implant
CROS hearing aids
quality of life
single‐
sided deafness
BAHA
binaural hearing
cochlear implant
CROS hearing aids
quality of life
single‐
sided deafness
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Objectives
To describe the treatment choice in a cohort of subjects with single-sided deafness (SSD) and asymmetric hearing loss (AHL). To assess the reliability of the treatment trials.
Design
In this national, ...
Show more >Objectives To describe the treatment choice in a cohort of subjects with single-sided deafness (SSD) and asymmetric hearing loss (AHL). To assess the reliability of the treatment trials. Design In this national, multicentre, prospective study, the choice of subjects was made after two consecutive trials of Contralateral Routing Of the Signal (CROS) hearing aids and a Bone Conduction Device (BCD) on a headband. Subjects could proceed with one of these two options, opt for cochlear implantation or decline all treatments. Setting Seven tertiary university hospitals. Participants One hundred fifty-five subjects with SSD or AHL fulfilling the candidacy criteria for cochlear implantation, with or without associated tinnitus. Main outcome measures After the two trials, the number of subjects choosing each option was described. Repeated assessments of both generic and auditory-specific quality of life were conducted, as well as hearing assessments (speech recognition in noise and horizontal localization). Results CROS was chosen by 75 subjects, followed by cochlear implantation (n = 51), BCD (n = 18) and abstention (n = 11). Patients who opted for cochlear implantation had a poorer quality of life (P = .03). The improvement of quality of life indices after each trial was significantly associated with the final treatment choice (P = .008 for generic indices, P = .002 for auditory-specific indices). The follow-up showed that this improvement had been overestimated in the CROS group, with a long-term retention rate of 52.5%. Conclusions More than one third of SSD/AHL subjects are unsatisfied after CROS and BCD trials. Repeated quality of life assessments help counselling the patient for his/her treatment choice.Show less >
Show more >Objectives To describe the treatment choice in a cohort of subjects with single-sided deafness (SSD) and asymmetric hearing loss (AHL). To assess the reliability of the treatment trials. Design In this national, multicentre, prospective study, the choice of subjects was made after two consecutive trials of Contralateral Routing Of the Signal (CROS) hearing aids and a Bone Conduction Device (BCD) on a headband. Subjects could proceed with one of these two options, opt for cochlear implantation or decline all treatments. Setting Seven tertiary university hospitals. Participants One hundred fifty-five subjects with SSD or AHL fulfilling the candidacy criteria for cochlear implantation, with or without associated tinnitus. Main outcome measures After the two trials, the number of subjects choosing each option was described. Repeated assessments of both generic and auditory-specific quality of life were conducted, as well as hearing assessments (speech recognition in noise and horizontal localization). Results CROS was chosen by 75 subjects, followed by cochlear implantation (n = 51), BCD (n = 18) and abstention (n = 11). Patients who opted for cochlear implantation had a poorer quality of life (P = .03). The improvement of quality of life indices after each trial was significantly associated with the final treatment choice (P = .008 for generic indices, P = .002 for auditory-specific indices). The follow-up showed that this improvement had been overestimated in the CROS group, with a long-term retention rate of 52.5%. Conclusions More than one third of SSD/AHL subjects are unsatisfied after CROS and BCD trials. Repeated quality of life assessments help counselling the patient for his/her treatment choice.Show less >
Language :
Anglais
Audience :
Internationale
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Submission date :
2022-12-08T01:34:20Z
2023-02-22T07:52:21Z
2023-02-22T11:36:41Z
2023-02-28T15:14:48Z
2023-03-01T06:53:58Z
2023-02-22T07:52:21Z
2023-02-22T11:36:41Z
2023-02-28T15:14:48Z
2023-03-01T06:53:58Z